The median survival time and influence factors of newly diagnosed pancreatic cancer cases of Shanghai residency during 2004–2009.

*<p>median and 95% CI was estimated using Kaplan Meier curve by each variable individually.</p>**<p>Hazard Ratio and 95% CI was estimated using multiple Cox regression model adjusted by surgical resection, age group, sex, site of tumor, TNM grade and stage.</p

the survival rate of pancreatic cancer patients among Shanghai residency underwent surgical resection, Shanghai Cancer Registry 2004–2009.

<p>Age <60: 1-year survival rate 54.8%, 3-year survival rate 19.8%, 5-year survival rate 13.9%, Age <70: 1-year survival rate 42.3%, 3-year survival rate 11.2%, 5-year survival rate 6.7%, Age>70: 1-year survival rate 40.8%, 3-year survival rate 12.3%, 5-year survival rate 6.2%.</p

The incidence rate of pancreatic cancer of Shanghai residency during 2004–2009 (1/100,000).

<p>The incidence rate of pancreatic cancer of Shanghai residency during 2004–2009 (1/100,000).</p

The incidence rate of pancreatic cancer of Shanghai residency during 2004–2009 (1/100,000).

*<p>Standardized by international age structure.</p